NCT03654716 2025-02-14Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric CancerDana-Farber Cancer InstitutePhase 1 Completed21 enrolled
NCT00000801 2012-11-01Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System LymphomaNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2 Completed33 enrolled